---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-125151"
form_type: "8-K"
ticker: "GERN"
cik: "0000886744"
company_name: "GERON CORP"
filed_at: "2026-03-26T23:59:59+00:00"
generated_at: "2026-05-15T08:57:06.063640+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Geron elects Patricia S. Andrews and Constantine Chinoporos to board

## Summary
- Patricia S. Andrews and Constantine Chinoporos elected as Class III directors effective March 25, 2026.
- Andrews appointed to Audit Committee; terms expire at 2026 Annual Meeting.
- Andrews is former CEO of Sumitomo Pharma Oncology and global head of oncology.
- Chinoporos served as COO/CBO at Applied Therapeutics and Albireo Pharmaceuticals.
- Both will receive standard non-employee director compensation and indemnification.

## SEC filing metadata
- accession: 0001193125-26-125151
- form_type: 8-K
- ticker: GERN
- cik: 0000886744
- company_name: GERON CORP
- filed_at: 2026-03-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/886744/000119312526125151/0001193125-26-125151-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/886744/000119312526125151/d192220d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-125151
- JSON: https://secwatch.observer/filing/0001193125-26-125151.json
- Plain text: https://secwatch.observer/filing/0001193125-26-125151.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.